19O A phase Ib trial of CFI-402257 in combination with weekly paclitaxel in patients with advanced HER2-negative (HER2-) breast cancer (aBC)P. Bedard,M. Mates, K.A. Gelmon,J. Hilton,D. Tu,I. Li, L. Rastgou, N. Drummond-Ivars,J. Edwards, D. Warr,C. Lohrisch,X. Song, A. Srikanthan,A. Robinson, L. Hagerman,L.K. Seymour,M. Rushton,D.W. CesconAnnals of Oncology（2020）引用 1|浏览54暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
